Recent News for CRBP - Corbus Pharmaceuticals Holdings, Inc.

Date Title
Nov 18 Corbus Pharma completes patient enrollment in mid-stage lenabasum study for CF
Nov 18 Corbus Pharmaceuticals Completes Enrollment of Phase 2b Study of Lenabasum for Treatment of Cystic Fibrosis
Nov 14 Edited Transcript of CRBP earnings conference call or presentation 7-Nov-19 1:30pm GMT
Nov 13 The Daily Biotech Pulse: Merck Goes Shopping, Nuvectra Files For Bankruptcy Protection, Opiant Rips Higher
Nov 12 Corbus Pharmaceuticals to Present at the Jefferies 2019 Global Healthcare Conference in London
Nov 12 We Think Corbus Pharmaceuticals Holdings (NASDAQ:CRBP) Can Afford To Drive Business Growth
Nov 11 Corbus Pharmaceuticals Updates Data from Lenabasum Open-Label Extension Studies in Systemic Sclerosis and Dermatomyositis at 2019 ACR Annual Meeting
Nov 10 The Week Ahead In Biotech: Adcom Test For Amarin's Fish Oil Pill, Agile Awaits FDA Verdict
Nov 10 Corbus Pharmaceuticals Holdings, Inc. (CRBP) CEO Yuval Cohen on Q3 2019 Results - Earnings Call Transcript
Nov 7 Corbus Pharmaceuticals (CRBP) Reports Q3 Loss, Tops Revenue Estimates
Nov 7 Corbus Pharmaceuticals EPS beats by $0.05, beats on revenue
Nov 7 Corbus Pharmaceuticals Reports 2019 Third Quarter Financial Results and Provides Clinical and Corporate Updates
Nov 5 3 Under-the-Radar Stocks Top Insiders Are Snapping Up
Nov 4 Corbus Pharmaceuticals to Host Conference Call and Webcast to Discuss Third Quarter 2019 Operational and Financial Results on November 7, 2019
Nov 1 Were Hedge Funds Right About Selling Corbus Pharmaceuticals (CRBP)?
Oct 13 What Percentage Of Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Shares Do Insiders Own?
Oct 9 The Daily Biotech Pulse: FDA Approves Clinuvel Drug, Aclaris Files Patent Lawsuit Against Taro, Viela Out-Licenses Autoimmune Disorder Drug
Oct 3 Corbus Pharmaceuticals Announces Presentation of Three Abstracts and New Lenabasum Data at 2019 ACR Annual Meeting
Oct 2 The Daily Biotech Pulse: J&J Settles Ohio Opioid Lawsuit, Teligent Explores Options For Certain Assets, Novartis Reports Cosentyx Data
Oct 1 Marijuana stocks are oversold — here’s how to know when to buy them
Oct 1 The Daily Biotech Pulse: Safety Scare For Anaptys' Psoriasis Drug, NewLink Genetics To Merge With Lumos, Insider Buy Props Up VBI Vaccines
Sep 13 Health Check: How Prudently Does Corbus Pharmaceuticals Holdings (NASDAQ:CRBP) Use Debt?
Sep 11 Cannabis Stock Gainers And Losers From September 11, 2019
Sep 9 Corbus Pharmaceuticals And Lenabasum In Systemic Sclerosis
Sep 6 FDA OKs Boehringer Ingelheim's Ofev for rare lung disease

Back to the Main CRBP Page...